About NAMMI THERAPEUTICS, INC.
Nammi Therapeutics, Inc. is a biotechnology company focused on developing immuno-oncology products that target immune activation specifically at tumor sites to minimize systemic side effects. The company utilizes innovative platform technologies such as Masked ImmunoCytokines and Nammisomes to create novel immunotherapies.
Development of immuno-oncology products targeting immune activation at tumor sitesCreation of Masked ImmunoCytokines (MICs) with tumor-specific activation mechanismsFormulation of Nammisomes, lipid-based nanoparticles containing immune modulator prodrugsDesign of therapies that modulate multiple immune functions in different cell typesIncorporation of mechanisms to maintain immune agents inactive in circulation and activate them at the tumor site
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to NAMMI THERAPEUTICS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.